J Ovarian Res 16(1):9
These insights should be interpreted with a qualified healthcare provider to contextualize your baseline metabolic profile and lifestyle constraints, not as a guarantee of specific weight loss or as a replacement for comprehensive medical evaluation
Hispanic adults with diabetes had the highest rate of GLP-1 use, at 31.3%, followed by Black non-Hispanic and White non-Hispanic adults, at 26.5% and 26.2%, respectively, the survey found
The costs of GLP-1 prescriptions utilized for weight loss purposes accounted for 10% or more of total annual claims filed for nearly half of employers respondents (47%) in one survey
In the small published human studies to date, BPC-157 was well tolerated, with no meaningful changes in cardiac, hepatic, renal, or metabolic markers